熱門資訊> 正文
Capricor Therapeutics prices $150M stock offering
2025-12-05 19:33
- Capricor Therapeutics (CAPR) shares popped over 4% premarket on Friday after the biotechnology company priced an offering to raise $150M.
- The offering includes 6M shares of common stock issued at a public offering price of $25.00 per share. Capricor also granted the underwriters a 30-day option to purchase up to an additional 900K shares.
- The company intends to use the net proceeds from the offering for the continued development and manufacturing of its product candidates, for working capital, and for general corporate purposes.
- The offering is expected to close on or about December 8, 2025, subject to the satisfaction of customary closing conditions.
- CAPR +4.8% premarket to $26.63
- Source: Press Release
More on Capricor Therapeutics, Inc.
- Capricor Therapeutics: Shares Soaring After DMD Study Win - Ball Now In FDA's Court
- Capricor Therapeutics, Inc. (CAPR) Q3 2025 Earnings Call Transcript
- Capricor: Post-CRL Path To DMD Cardiomyopathy Approval In 2026
- Capricor Therapeutics launches proposed public offering of common stock
- Capricor signals pivotal HOPE-3 data imminent as FDA review process advances for deramiocel
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
